AtriCure (ATRC) Shares Outstanding (Diluted Average) (2019 - 2026)

AtriCure (ATRC) has 8 years of Shares Outstanding (Diluted Average) data on file, last reported at $49.0 million in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $49.0 million, up 3.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $49.0 million (up 3.49% YoY), and the FY2025 annual result was $47.8 million, up 1.67% from the prior year.
• Shares Outstanding (Diluted Average) rose to $49.0 million in Q1 2026 per ATRC's latest filing, from $47.8 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $49.0 million in Q1 2026 and troughed at $45.5 million in Q1 2022.
• A 5-year average of $46.7 million and a median of $46.7 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Diluted Average) slipped 0.68% in 2022, then gained 3.49% in 2026.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $45.7 million in 2022, then climbed by 1.24% to $46.3 million in 2023, then advanced by 1.42% to $47.0 million in 2024, then rose by 1.67% to $47.8 million in 2025, then climbed by 2.71% to $49.0 million in 2026.
• Business Quant data shows ATRC's Shares Outstanding (Diluted Average) at $49.0 million in Q1 2026, $47.8 million in Q4 2025, and $47.7 million in Q3 2025.